New Technologies
IMG_May102021at12503PM.jpg
New TechnologiesAllergan Aesthetics Set to Acquire Soliton for $550MAllergan Aesthetics Set to Acquire Soliton for $550M
The acquisition would give AbbVie’s Allergan Aesthetics access to Resonic, a non-invasive treatment for the short-term improvement in the appearance of cellulite.
Sign up for the QMED & MD+DI Daily newsletter.